Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Cryo Cell International (CCEL) Shares Outstanding (Weighted Average) (2018 - 2020)

Historic Shares Outstanding (Weighted Average) for Cryo Cell International (CCEL) over the last 6 years, with Q2 2020 value amounting to $7.5 million.

  • Cryo Cell International's Shares Outstanding (Weighted Average) fell 330.27% to $7.5 million in Q2 2020 from the same period last year, while for May 2020 it was $7.5 million, marking a year-over-year decrease of 330.27%. This contributed to the annual value of $7.8 million for FY2019, which is 444.56% up from last year.
  • Cryo Cell International's Shares Outstanding (Weighted Average) amounted to $7.5 million in Q2 2020, which was down 330.27% from $7.5 million recorded in Q1 2020.
  • Over the past 5 years, Cryo Cell International's Shares Outstanding (Weighted Average) peaked at $7.8 million during Q2 2019, and registered a low of $7.2 million during Q2 2018.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $7.7 million (2018), whereas its average is $7.6 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first skyrocketed by 766.98% in 2019, then tumbled by 333.56% in 2020.
  • Over the past 3 years, Cryo Cell International's Shares Outstanding (Weighted Average) (Quarter) stood at $7.5 million in 2018, then increased by 4.45% to $7.8 million in 2019, then dropped by 3.2% to $7.5 million in 2020.
  • Its last three reported values are $7.5 million in Q2 2020, $7.5 million for Q1 2020, and $7.8 million during Q4 2019.